Stephen L Sabba

LGND

Stephen L Sabba serves as director at Ligand Pharmaceuticals Incorporated (LGND). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$842.7K

Net Position

Net Seller

$842.7K

Companies Traded

LGND

Active Period

May 2023 – Mar 2026

3 total trades

Most Recent

Sell LGND

Mar 25, 2026 · $207.9K

Stephen L Sabba's Insider Trading at Ligand Pharmaceuticals Incorporated (LGND)

Buys

0 · $0.00

Sells

3 · $842.7K

Total Shares Bought

Total Shares Sold

9,301

LGND Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 25, 2026	Sell	1,000	$207.87	$207.9K	32,793
Mar 7, 2024	Sell	1,893	$74.30	$140.7K	28,926
May 12, 2023	Sell	6,408	$77.13	$494.2K	25,784

Related Insiders

KOZARICH JOHN W

Director

LGNDSell · Apr 2, 2026

Andrew Reardon

officer: CLO & Secretary

LGNDSell · Apr 2, 2026

LAMATTINA JOHN L

Director

LGNDSell · Mar 31, 2026

Octavio Espinoza

officer: Chief Financial Officer

LGNDSell · Mar 13, 2026

Nancy Ryan Gray

Director

LGNDSell · Nov 12, 2025

Jason Aryeh

Director

LGNDSell · Sep 24, 2025

Todd C Davis

Chief Executive Officer

LGNDBuy · May 13, 2025

Explore More Insider Trading Data

LGND Insider Trading Activity

View all insider trades at Ligand Pharmaceuticals Incorporated

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity